SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GAIL (India), Atul and RR Kabel to see some action today

08 Aug 2025 Evaluate

GAIL (India) and Hindustan Copper (HCL) have signed a Memorandum of Understanding (MoU) to collaborate on the exploration and development of critical mineral resources in India and overseas. This strategic partnership between Hindustan Copper and GAIL marks a significant development in India's critical minerals sector, potentially enhancing the country's self-reliance in these crucial resources and supporting its growing technology and clean energy industries. It also reflects India’s growing focus on sustainable development and the need to reduce dependence on imported resources by strengthening domestic capabilities in mining and mineral processing.

RR Kabel has launched a series of next-generation wire solutions crafted to address the evolving demands of Indian homes and infrastructure in an era marked by rising temperatures and increasing electrical loads. The new product line features Flamex HR+FR, Superex Green HR+FR, and Firex LS0H-EBXL-each engineered to deliver superior safety, performance, and sustainability across diverse applications.

Arisinfra Solutions' Subsidiary Company -- ArisUnitern RE Solutions (formerly known as ArisUnitern) has received a provisional purchase order from AVS Housing and Construction LLP (AVS Group) for a Development Management Mandate worth approximately Rs 40 crore. The said order is expected to be executed in around 1020 days.

Mamata Machinery has secured its first export order for its state-of-the-art 9-layer blown film plant under its Co-Extrusion product segment. The order, valued at around Rs 8.5 crore, has been placed by a new customer based in Latin America. This follows last week’s announcement of Mamata’s first-ever order for a 9-layer blown film plant from an Indian customer. This advanced 9-layer blown film plant will be commissioned to produce high barrier films, catering to critical food packaging applications that require enhanced product protection and extended shelf life. Delivery of this order is scheduled for Q3FY27.

Atul and Buckman Laboratories (Asia) (Buckman), a wholly owned subsidiary of Bulab Holdings, Inc., a global leader in water treatment, process chemistry and digital solutions, headquartered in Memphis, Tennessee, USA, have signed an agreement for a strategic joint venture (JV) to manufacture, market and deliver advanced water treatment with digital and chemical solutions in India and Sri Lanka, and anticipate that ancillary agreements and incorporation related documentation will be completed by early October 2025. The JV, which will do business as ‘Atul-Buckman’, will leverage and combine the widely recognised portfolio of water treatment chemistries, digital solutions and technical expertise of Buckman and strong manufacturing capabilities, market access and distribution strength of Atul in India. 

Zydus Lifesciences has received Notice of Compliance (NoC) from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg. This is the group’s first NOC approval in Canada. Varenicline is used as an aid in smoking cessation. It is a partial nicotinic acetylcholine receptor agonist, designed to partially activate this system while displacing nicotine at its sites of action in the brain. ZDS-Varenicline tablets will be produced at Zydus Lifescience, SEZ, Ahmedabad. Varenicline tablets had annual sales of 15 million Canadian dollar in Canada (IQVIA MAT December 2024).

Kilburn Engineering has received approval for a capital expenditure plan of around Rs 30 crore towards capacity addition and improving cost efficiency at company’s Manufacturing Facility located in Saravali, Bhiwandi, Maharashtra. The Board of Directors in their meeting held on August 07, 2025, has approved the same. The proposed capacity is to be added up to March 2026. This capacity expansion will meet captive demand of increasing orders.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: